Australia markets closed

Koninklijke Philips N.V. (RYLPF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
33.82-0.34 (-1.00%)
At close: 02:17PM EST
Full screen
Trade prices are not sourced from all markets
Previous close34.16
Bid0.00 x 0
Ask0.00 x 0
Day's range33.44 - 33.82
52-week range32.57 - 61.06
Avg. volume54,114
Market cap29.992B
Beta (5Y monthly)0.80
PE ratio (TTM)7.19
Earnings dateN/A
Forward dividend & yield1.03 (2.99%)
Ex-dividend date10 May 2021
1y target estN/A
  • GlobeNewswire

    Philips integrates cloud-based AI and 3D mapping into its Mobile C-arm System Series – Zenition – to enhance workflow efficiency and improve endovascular treatment outcomes

    Philips Zention mobile C-arm platform vascular application Cydar EV Maps January 18, 2021 New capabilities on Philips Image Guided Therapy Mobile C-arm System – Zenition – and collaboration with Cydar offer the latest advances in endovascular treatment Partnership adds new innovations to the Zenition platform to elevate the clinical experience, enhance workflow efficiency and help improve patient outcomes Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in healt

  • GlobeNewswire

    Philips provides update on its financial performance in Q4 2021

    January 12, 2022 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today provided an update on the fourth-quarter 2021 and full-year 2021 financial results. Group sales for the quarter are expected to be approximately EUR 4.9 billion, which is around EUR 350 million lower than Philips’ earlier expectations. This is mainly due to intensified global supply chain shortages (primarily related to electronic components and freight capacity), as we

  • GlobeNewswire

    Tactile Medical Announces New Appointments to Board of Directors

    Appoints Valerie Asbury and Brent ShaferMINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced the appointment of Valerie L. Asbury and D. Brent Shafer to the Company’s Board of Directors (“Board”), effective January 5, 2022. Ms. Asbury will serve as a member of both the Audit Commi